BRIEF-Jerusalem Pharmaceuticals Q1 income rises
BRIEF-Cryosite says Mark Byrne has been appointed interim CEO
* Agreed with Andrew Shine (CEO), that his notice period will now be effective 30th June 2017 Source text for Eikon: Further company coverage: